Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up

J. D. Clemens, D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, M. R. Rao, M. R. Khan, Md Yunus, N. Huda, B. F. Stanton, B. A. Kay, R. Eeckels, J. D. Clemens, M. R. Rao, B. A. Kay, D. A. Sack, J. R. Harris, B. F. Stanton, S. WalterR. Eeckels, A. M. Svennerholm, J. Holmgren

Research output: Contribution to journalArticle

Abstract

The protective efficacy (PE) of B subunit killed whole-cell (BS-WC) and killed whole-cell-only (WC) oral cholera vaccines was assessed in a randomised double-blind field trial among children aged 2-15 years and women over 15 years in rural Bangladesh. Among the 62 285 subjects who received three doses of BS-WC, WC, or Escherichia coli K12 strain placebo, cumulative PE at 3 years of follow-up was 50% for BS-WC and 52% for WC. PE was similar against severe and non-severe cholera, but was significantly lower in children who were vaccinated at 2-5 years (26% for BS-WC; 23% for WC) than in older persons (63% for BS-WC; 68% for WC). Among persons vaccinated at 2-5 years, protection at 4-6 months of follow-up was similar to that for older persons, but rapidly waned thereafter and was not evident during the third year of follow-up. In contrast, persons vaccinated at older ages were protected even in the third year of follow-up (PE 40% for BS-WC; 62% for WC). PE was substantially higher against classical cholera (58% for BS-WC; 60% for WC) than against El Tor cholera (39% and 40%).

Original languageEnglish (US)
Pages (from-to)270-273
Number of pages4
JournalThe Lancet
Volume335
Issue number8684
DOIs
StatePublished - Feb 3 1990
Externally publishedYes

Fingerprint

Cholera Vaccines
Bangladesh
Cholera
Escherichia coli K12

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clemens, J. D., Sack, D. A., Harris, J. R., van Loon, F., Chakraborty, J., Ahmed, F., ... Holmgren, J. (1990). Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. The Lancet, 335(8684), 270-273. https://doi.org/10.1016/0140-6736(90)90080-O

Field trial of oral cholera vaccines in Bangladesh : results from three-year follow-up. / Clemens, J. D.; Sack, D. A.; Harris, J. R.; van Loon, F.; Chakraborty, J.; Ahmed, F.; Rao, M. R.; Khan, M. R.; Yunus, Md; Huda, N.; Stanton, B. F.; Kay, B. A.; Eeckels, R.; Clemens, J. D.; Rao, M. R.; Kay, B. A.; Sack, D. A.; Harris, J. R.; Stanton, B. F.; Walter, S.; Eeckels, R.; Svennerholm, A. M.; Holmgren, J.

In: The Lancet, Vol. 335, No. 8684, 03.02.1990, p. 270-273.

Research output: Contribution to journalArticle

Clemens, JD, Sack, DA, Harris, JR, van Loon, F, Chakraborty, J, Ahmed, F, Rao, MR, Khan, MR, Yunus, M, Huda, N, Stanton, BF, Kay, BA, Eeckels, R, Clemens, JD, Rao, MR, Kay, BA, Sack, DA, Harris, JR, Stanton, BF, Walter, S, Eeckels, R, Svennerholm, AM & Holmgren, J 1990, 'Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up', The Lancet, vol. 335, no. 8684, pp. 270-273. https://doi.org/10.1016/0140-6736(90)90080-O
Clemens JD, Sack DA, Harris JR, van Loon F, Chakraborty J, Ahmed F et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. The Lancet. 1990 Feb 3;335(8684):270-273. https://doi.org/10.1016/0140-6736(90)90080-O
Clemens, J. D. ; Sack, D. A. ; Harris, J. R. ; van Loon, F. ; Chakraborty, J. ; Ahmed, F. ; Rao, M. R. ; Khan, M. R. ; Yunus, Md ; Huda, N. ; Stanton, B. F. ; Kay, B. A. ; Eeckels, R. ; Clemens, J. D. ; Rao, M. R. ; Kay, B. A. ; Sack, D. A. ; Harris, J. R. ; Stanton, B. F. ; Walter, S. ; Eeckels, R. ; Svennerholm, A. M. ; Holmgren, J. / Field trial of oral cholera vaccines in Bangladesh : results from three-year follow-up. In: The Lancet. 1990 ; Vol. 335, No. 8684. pp. 270-273.
@article{259a9b5f1dfa454c976e9b50d3191f92,
title = "Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up",
abstract = "The protective efficacy (PE) of B subunit killed whole-cell (BS-WC) and killed whole-cell-only (WC) oral cholera vaccines was assessed in a randomised double-blind field trial among children aged 2-15 years and women over 15 years in rural Bangladesh. Among the 62 285 subjects who received three doses of BS-WC, WC, or Escherichia coli K12 strain placebo, cumulative PE at 3 years of follow-up was 50{\%} for BS-WC and 52{\%} for WC. PE was similar against severe and non-severe cholera, but was significantly lower in children who were vaccinated at 2-5 years (26{\%} for BS-WC; 23{\%} for WC) than in older persons (63{\%} for BS-WC; 68{\%} for WC). Among persons vaccinated at 2-5 years, protection at 4-6 months of follow-up was similar to that for older persons, but rapidly waned thereafter and was not evident during the third year of follow-up. In contrast, persons vaccinated at older ages were protected even in the third year of follow-up (PE 40{\%} for BS-WC; 62{\%} for WC). PE was substantially higher against classical cholera (58{\%} for BS-WC; 60{\%} for WC) than against El Tor cholera (39{\%} and 40{\%}).",
author = "Clemens, {J. D.} and Sack, {D. A.} and Harris, {J. R.} and {van Loon}, F. and J. Chakraborty and F. Ahmed and Rao, {M. R.} and Khan, {M. R.} and Md Yunus and N. Huda and Stanton, {B. F.} and Kay, {B. A.} and R. Eeckels and Clemens, {J. D.} and Rao, {M. R.} and Kay, {B. A.} and Sack, {D. A.} and Harris, {J. R.} and Stanton, {B. F.} and S. Walter and R. Eeckels and Svennerholm, {A. M.} and J. Holmgren",
year = "1990",
month = "2",
day = "3",
doi = "10.1016/0140-6736(90)90080-O",
language = "English (US)",
volume = "335",
pages = "270--273",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8684",

}

TY - JOUR

T1 - Field trial of oral cholera vaccines in Bangladesh

T2 - results from three-year follow-up

AU - Clemens, J. D.

AU - Sack, D. A.

AU - Harris, J. R.

AU - van Loon, F.

AU - Chakraborty, J.

AU - Ahmed, F.

AU - Rao, M. R.

AU - Khan, M. R.

AU - Yunus, Md

AU - Huda, N.

AU - Stanton, B. F.

AU - Kay, B. A.

AU - Eeckels, R.

AU - Clemens, J. D.

AU - Rao, M. R.

AU - Kay, B. A.

AU - Sack, D. A.

AU - Harris, J. R.

AU - Stanton, B. F.

AU - Walter, S.

AU - Eeckels, R.

AU - Svennerholm, A. M.

AU - Holmgren, J.

PY - 1990/2/3

Y1 - 1990/2/3

N2 - The protective efficacy (PE) of B subunit killed whole-cell (BS-WC) and killed whole-cell-only (WC) oral cholera vaccines was assessed in a randomised double-blind field trial among children aged 2-15 years and women over 15 years in rural Bangladesh. Among the 62 285 subjects who received three doses of BS-WC, WC, or Escherichia coli K12 strain placebo, cumulative PE at 3 years of follow-up was 50% for BS-WC and 52% for WC. PE was similar against severe and non-severe cholera, but was significantly lower in children who were vaccinated at 2-5 years (26% for BS-WC; 23% for WC) than in older persons (63% for BS-WC; 68% for WC). Among persons vaccinated at 2-5 years, protection at 4-6 months of follow-up was similar to that for older persons, but rapidly waned thereafter and was not evident during the third year of follow-up. In contrast, persons vaccinated at older ages were protected even in the third year of follow-up (PE 40% for BS-WC; 62% for WC). PE was substantially higher against classical cholera (58% for BS-WC; 60% for WC) than against El Tor cholera (39% and 40%).

AB - The protective efficacy (PE) of B subunit killed whole-cell (BS-WC) and killed whole-cell-only (WC) oral cholera vaccines was assessed in a randomised double-blind field trial among children aged 2-15 years and women over 15 years in rural Bangladesh. Among the 62 285 subjects who received three doses of BS-WC, WC, or Escherichia coli K12 strain placebo, cumulative PE at 3 years of follow-up was 50% for BS-WC and 52% for WC. PE was similar against severe and non-severe cholera, but was significantly lower in children who were vaccinated at 2-5 years (26% for BS-WC; 23% for WC) than in older persons (63% for BS-WC; 68% for WC). Among persons vaccinated at 2-5 years, protection at 4-6 months of follow-up was similar to that for older persons, but rapidly waned thereafter and was not evident during the third year of follow-up. In contrast, persons vaccinated at older ages were protected even in the third year of follow-up (PE 40% for BS-WC; 62% for WC). PE was substantially higher against classical cholera (58% for BS-WC; 60% for WC) than against El Tor cholera (39% and 40%).

UR - http://www.scopus.com/inward/record.url?scp=0025157072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025157072&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(90)90080-O

DO - 10.1016/0140-6736(90)90080-O

M3 - Article

C2 - 1967730

AN - SCOPUS:0025157072

VL - 335

SP - 270

EP - 273

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8684

ER -